ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in VNDA — Vanda Pharmaceuticals Inc.

CIK 1164508 BOSTON, MA

Position in VNDA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$178,587

-$1,489,694 QoQ

Shares Held

29,181

-87.9% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#86

of 172 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,519,535,758 across 72 Biotechnology names. VNDA ranks #68 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	738,378	$366,774,503
2	INCY	Incyte Corp	2,744,958	$311,168,438
3	REGN	Regeneron Pharmaceuticals, Inc.	393,685	$245,478,344
4	EXEL	Exelixis, Inc.	4,365,926	$237,550,033
5	GMAB	Genmab A/S	4,975,324	$136,672,150
6	RPRX	Royalty Pharma plc	2,435,341	$136,549,569
7	HALO	Halozyme Therapeutics, Inc.	1,704,623	$133,420,842
8	ONC	BeOne Medicines Ltd.	249,758	$71,173,537

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$178,587	29,181	-87.9%	Shares	Defined	2026-08-13
2026-03-31	$1,668,281	241,430	+710.8%	Shares	Defined	2026-05-14
2023-09-30	$128,640	29,778	-70.7%	Shares	Defined	2023-11-14
2022-03-31	$1,150,939	101,763	-61.5%	Shares	Defined	2022-05-13
2021-12-31	$4,150,460	264,529	-22.7%	Shares	Defined	2022-02-14
2021-09-30	$5,866,045	342,243	-18.8%	Shares	Defined	2021-11-12
2021-06-30 ALXN	—	1,002,319	+1113.5%	Shares	Defined	2021-08-13
2021-06-30	$9,064,787	421,422	—	Shares	Defined	2021-08-13
2021-03-31 ALXN	—	82,600	+686.1%	Shares	Defined	2021-05-14
2020-06-30 ALXN	—	10,508	-96.6%	Shares	Defined	2020-08-12
2020-03-31 ALXN	—	312,157	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.